Concepedia

Publication | Closed Access

Randomized, Double-Masked, Placebo-Controlled Study to Assess the Ocular Safety of Mirabegron in Healthy Volunteers

30

Citations

29

References

2013

Year

Abstract

Mirabegron 100 mg orally once daily for 8 weeks of treatment does not increase the IOP, and was generally safe and well tolerated.

References

YearCitations

Page 1